Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...
The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...
Merck (MRK) shares drop 8% premarket as 2025 outlook falls short of Wall Street estimates, despite beating Q4 expectations ...
Gardasil shipment pause, weak guidance, and looming Keytruda risks send investors scrambling--can Merck turn things around?
The drug company’s outlook for 2025 and a slide in sales of its HPV vaccine, Gardasil, hit shares.
This update provides insights into critical global health developments, including Merck's halt on Gardasil shipments to China ...
Kennedy Jr.'s pledge to transfer his financial interest in vaccine lawsuits to his family, legal experts have criticized the ...
RFK Jr. said he would give up the fees after senators questioned him about the lawsuits in a pair of hearings.